BLRX

BioLineRX
BLRX

29 hedge funds and large institutions have $2.46M invested in BioLineRX in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0% more ownership

Funds ownership: 0% → 0% (+0%)

11% less call options, than puts

Call options by funds: $635K | Put options by funds: $715K

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$635K
Puts
$715K
Net Calls
Net Calls Change

Top Buyers

1
+$382K
2
+$279K
3
+$88K
4
RG
Rathbones Group
United Kingdom
+$72.5K
5
AMBIA
Allen Mooney & Barnes Investment Advisors
Georgia
+$45.5K

Top Sellers

1
-$280K
2
-$157K
3
-$155K
4
PAM
PVG Asset Management
Colorado
-$98.6K
5
LPL Financial
LPL Financial
California
-$20.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4K
27
$3.46K
28
$364
29
$64
30
–
31
–
32
–
33
–
1
2